Fludarabine (Fludara®) Plus Alemtuzumab (CAMPATH®, MabCampath®) vs Fludarabine Alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients

Clinical trial NCT00086580 · COMPLETED

Trial details

NCT number: NCT00086580
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

B-Cell Chronic Lymphocytic Leukemia

Start date: 2004-07-01
Primary completion: 2010-06-01
Enrollment: 335

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.